Mauro Dispagna
Urology · Philadelphia, PANPI 1528642626
Payments from drug & device makers
Across 86 payments — averaging $70.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Boston Scientific$875
- Coloplast$765
- Photocure Inc$409
- Astellas Pharma US Inc$294
- Calyxo, Inc.$280
- plus $2K from 13 others
What the payments were for
- Travel & lodging$60510%
- Food & beverage$5,14785%
- Education$2945%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 28 | $1,682 |
| Boston Scientific | 21 | $875 |
| Coloplast | 5 | $765 |
| Photocure Inc | 4 | $409 |
| Astellas Pharma US Inc | 3 | $294 |
| Calyxo, Inc. | 2 | $280 |
| Johnson & Johnson | 5 | $250 |
| Merck | 3 | $238 |
| Teleflex LLC | 2 | $196 |
| AbbVie | 3 | $156 |
| Janssen Scientific Affairs, LLC | 1 | $141 |
| Ferring Pharmaceuticals Inc. | 1 | $121 |
| Angiodynamics, Inc. | 1 | $121 |
| Palette Life Sciences, Inc. | 1 | $117 |
| Axonics, Inc. | 1 | $112 |
| Procept Biorobotics Corporation | 1 | $110 |
| Intuitive Surgical | 1 | $110 |
| Bayer | 2 | $45 |
| Accord Healthcare, Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTERSTIM$743
- TITAN$605
- Cysview$394
- CVAC Aspiration System$280
- Erleada$268
- GENERAL ERECTILE DYSFUNCTION$218
- rezum Generator$209
- AKEEGA$127
- Nanoknife$121
- KEYTRUDA$118
- BOTOX$114
- Axonics$112
- AquaBeam Robotic System$110
- Da Vinci Surgical System$110
How this compares
$6,046 in reported general payments places this provider in the 70th percentile of 596 urology providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 19 | $15,172 |
| GemtesaVibegron | 22 | $12,048 |
| EliquisApixaban | 13 | $4,296 |
| Tamsulosin Hcl | 49 | $1,245 |
| Dutasteride | 12 | $990 |
| Testosterone | 12 | $609 |
| Solifenacin Succinate | 15 | $550 |
| Finasteride | 18 | $483 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 32 | $229 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 12 | $169 |
| Cephalexin | 19 | $83 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 17 | $61 |
| Ciprofloxacin Hcl | 12 | $27 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $294 | $15,17219 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 596 urology providers in Pennsylvania.
Other urology in Philadelphia
- Costas LallasPhiladelphia$3.6M
- Stanley MalkowiczPhiladelphia$882K
- Demetrius BagleyPhiladelphia$739K
- Gregory TasianPhiladelphia$645K
- Eugene PietzakPhiladelphia$544K
- Philip AbboshPhiladelphia$472K
- Trinity BivalacquaPhiladelphia$361K
- Edouard TrabulsiPhiladelphia$254K
- Paul ChungPhiladelphia$242K
- Daniel EunPhiladelphia$226K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.